TY  - GEN
AU  - Lotery,Andrew
AU  - Sivaprasad,Sobha
AU  - O'Connell,Abby
AU  - Harris,Rosie A
AU  - Culliford,Lucy
AU  - Ellis,Lucy
AU  - Cree,Angela
AU  - Madhusudhan,Savita
AU  - Behar-Cohen,Francine
AU  - Chakravarthy,Usha
AU  - Peto,Tunde
AU  - Rogers,Chris A
AU  - Reeves,Barnaby C
TI  - Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
SN  - 1474-547X
PY  - 2020///0206
KW  - Adult
KW  - Central Serous Chorioretinopathy
KW  - drug therapy
KW  - Chronic Disease
KW  - Double-Blind Method
KW  - Eplerenone
KW  - adverse effects
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mineralocorticoid Receptor Antagonists
KW  - Treatment Outcome
KW  - Visual Acuity
KW  - drug effects
KW  - Young Adult
KW  - Assessment of Medication Adherence
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S0140-6736(19)32981-2
ER  -